SCHEMBL22139397

SCHEMBL22139397

O=C1C=C(O)/C(=C2/C(=O)C(c3c(O)c(Cc4ccccc4)c(O)c(Cc4ccccc4)c3O)=C2O)C(O)=C1Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XIAP P98170 5/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ ABCB1 P08183 1/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ ELANE P08246 2/20 0.34
▸ NQO1 P15559 2/20 0.34
▸ HPGD P15428 1/20 0.33
▸ PTPN1 P18031 1/20 0.32
▸ CTSG P08311 1/20 0.32
▸ SHBG P04278 1/20 0.31
▸ TYMP P19971 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ MAOB P27338 1/20 0.31
▸ JAK2 O60674 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22139358 0.90 XIAP (0.39) XIAPMAPK1CYP1A2CYP2C9HIF1A
SCHEMBL22139353 0.85 MAPK1 (0.48) XIAPMAPK1CYP1A2CYP2C9HIF1A
SCHEMBL22139359 0.79 MEN1 (0.42) MAPK1CYP1A2CYP2C9HIF1AABCB1
SCHEMBL22139361 0.78 XIAP (0.35) XIAP
SCHEMBL22139373 0.75 MAPK1 (0.43) XIAPMAPK1CYP1A2CYP2C9HIF1A
SCHEMBL22139362 0.72 XIAP (0.34) XIAPKDM4EALDH1A1MAPTPKM
SCHEMBL12757261 0.69 XIAP (0.73) XIAPMAPK1CYP1A2CYP2C9HIF1A
SCHEMBL22139376 0.68 HSP90AA1 (0.30) —
SCHEMBL22139372 0.66 ALOX5 (0.34) XIAPMAPK1CYP2C9KDM4EALDH1A1
SCHEMBL22139357 0.65 GABRA1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200199058-A1 SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES NITTO DENKO CORPORATION (JP) 2020-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200199058-A1 SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES SQLE, FDFT1, ALDH1A2 XIAP 930/4885MAPK1 2564/4885CYP1A2 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback